Stories by
Sydney Lupkin
Pharmaceuticals Correspondent
Drugstores say Medicare's $50 obesity drug program is catching on
Sydney Lupkin | Aug 26, 2026, 9:11 PM UTC
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
What to know about Dr. Heidi Overton, Trump's pick to lead the FDASydney Lupkin | Aug 20, 2026, 4:49 PM UTC
FDA weighs a new kind of flu shot based on technology RFK Jr. has questionedSydney Lupkin | Aug 1, 2026, 11:00 AM UTC
The Trump administration's move to end subsidies for Medicare drug plans could cost consumersSydney Lupkin | Jul 29, 2026, 8:58 PM UTC
TrumpRx promised a supermarket for cheaper drugs but delivered a boutiqueSydney Lupkin | Jul 16, 2026, 9:00 AM UTC

Trouble getting weight loss drugs covered by insurance? Here's what to know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won't cover it, you have options.
Sydney Lupkin | Jun 23, 2026, 9:00 AM UTC

Primary care doctors raise alarm as telehealth companies get involved in obesity drugs
Telehealth companies offer lifestyle support so people taking obesity drugs can have the most success losing weight. But employers also want the telehealth providers to limit spending on the drugs.
Sydney Lupkin | Jun 14, 2026, 9:00 AM UTC

World Health Organization declares Ebola outbreak in Congo a global health emergency
Health officials are working to contain a new Ebola outbreak in the Democratic Republic of Congo. There's no approved vaccine for the strain of the virus that's spreading.
Sydney Lupkin | May 16, 2026, 6:37 PM UTC

FDA commissioner resigns after tumultuous tenure
The resignation ends Dr. Marty Makary's management of the Food and Drug Administration, which was marked by turmoil and controversy.
Sydney Lupkin | May 12, 2026, 7:35 PM UTC

How a pill approved 25 years ago transformed cancer treatment
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer care.
Sydney Lupkin | May 10, 2026, 11:00 AM UTC

